Metacognitive Therapy for Comorbid Insomnia

Norwegian University of Science and Technology

Overview

The purpose of this study is to determine the effect of meta-cognitive therapy for insomnia.

This study is a randomized controlled trial with 50 patients with a psychiatric disorder and insomnia. The patients will be randomized into two groups of 25 patients. The first group receives meta-cognitive therapy, whereas the second group will be assigned to a waiting list control.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Secondary Insomnia

Interventions

meta-cognitive therapyBEHAVIORAL

Meta-cognitive therapy

waiting listOTHER

waiting list control

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Insomnia secondary to a primary psychiatric disorder Exclusion Criteria: * substance abuse, psychotic symptoms, suicidal intentions, severe organic disorder or psychiatric disorder where sleep restriction is not advised, organic sleep disorder.

Outcomes

Primary Outcomes

Scores on rating scales for sleep quality

Time frame: one year

Secondary Outcomes

Scores on rating scales for depression, psychiatric symptom severity, and cognitive processing.

Time frame: one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.